Potent immune responses induced by a Salmonella ghost delivery system that expresses the recombinant Stx2eB, FedF, and FedA proteins of the Escherichia coli-producing F18 and Shiga toxin in a murine model and evaluation of its protective effect as a porcine vaccine candidate

References

• Bosworth BT, Samuel JE, Moon HW, O'Brien AD, Gordon VM, Whipp SC. 1996. Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun. 64:55–60.
   PubMed Web of Science ®Google Scholar
• Bounous DI, Campagnoli RP, Brown J. 1992. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis. 36:1022–1027.
   PubMed Web of Science ®Google Scholar
• Chaudhari AA, Jawale CV, Kim SW, Lee JH. 2012. Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens. Vet Res. 43:44–54.
   PubMed Web of Science ®Google Scholar
• Chen J, Li N, She F. 2014. Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice. Vaccine. 32:6054–6060.
   PubMed Web of Science ®Google Scholar
• Coddens A, Verdonck F, Tiels P, Rasschaert K, Goddeeris B, Cox E. 2007. The age-dependent expression of the F18 E. coli receptor on porcine gut epithelial cells is positively correlated with the presence of histo-blood group antigens. Vet Microbio l. 122:332–341.
   PubMed Web of Science ®Google Scholar
• Del Prete GF, De Carli M, Ricci M, Romagnani S. 1991. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J Exp Med. 174:809–813.
   PubMed Web of Science ®Google Scholar
• Ebensen T, Paukner S, Link C, Kudela P, de Domenico C, Lubitz W, Guzman CA. 2004. Bacterial ghosts are an efficient delivery system for DNA vaccines. J Immun. 172:6858–6865.
   PubMed Web of Science ®Google Scholar
• Fricke R, Bastert O, Gotter V, Brons N, Kamp J, Selbitz H. 2015. Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study. Porcine Health Manage. 1:6.
   PubMedGoogle Scholar
• Gordon VM, Whipp SC, Moon HW, O'Brien AD, Samuel JE. 1992. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun. 60:485–490.
   PubMed Web of Science ®Google Scholar
• Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R, Decostere A. 2004. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol. 100:255–268.
   PubMed Web of Science ®Google Scholar
• Humphreys S, Rowley G, Stevenson A, Anjum MF, Woodward MJ, Gilbert S, Kormanec J, Roberts M. 2004. Role of the two-component regulator CpxAR in the virulence of Salmonella enterica serotype Typhimurium. Infect Immun. 72:4654–4661.
   PubMed Web of Science ®Google Scholar
• Hur J, Kim CS, Eo SK, Park S, Lee JH. 2015. Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model. Vet Quart. 35:125 –132.
   PubMed Web of Science ®Google Scholar
• Hur J, Lee JH. 2010. Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis. Vet Microbiol. 143:270–276.
   PubMed Web of Science ®Google Scholar
• Hur J, Lee JH. 2015. A new enterotoxigenic Escherichia coli vaccine candidate constructed using a Salmonella ghost delivery system: comparative evaluation with a commercial vaccine for neonatal piglet colibacillosis. Vet Immunol Immunopathol. 164:101–109.
   PubMed Web of Science ®Google Scholar
• Imberechts H, De Greve H, Lintermans P. 1992. The pathogenesis of edema disease in pigs. A review. Vet Microbiol. 31:221–233.
   PubMed Web of Science ®Google Scholar
• Jawale CV, Kim SW, Lee JH. 2014. Tightly regulated bacteriolysis for production of empty Salmonella Enteritidis envelope. Vet Microbiol. 169:179–187.
   PubMed Web of Science ®Google Scholar
• Jawale CV, Lee JH. 2014. Characterization of a Salmonella Typhimurium ghost carrying an adjuvant protein as a vaccine candidate for the protection of chickens against virulent challenge. Avian Pathol. 43:506–513.
   PubMed Web of Science ®Google Scholar
• Johansen M, Andresen LO, Jorsal SE, Thomsen LK, Waddell TE, Gyles CL. 1997. Prevention of edema disease in pigs by vaccination with verotoxin 2e toxoid. Can J Vet Res. 61:280–285.
   PubMed Web of Science ®Google Scholar
• Kim SW, Moon KH, Baik HS, Kang HY, Kim SK, Bahk JD, Hur J, Lee JH. 2009. Changes of physiological and biochemical properties of Salmonella enterica serovar Typhimurium by deletion of cpxR and lon genes using allelic exchange method. J Microbiol Methods. 79:314–320.
   PubMed Web of Science ®Google Scholar
• Kudela P, Paukner S, Mayr UB, Cholujova D, Schwarczova Z, Sedlak J, Bizik J, Lubitz W. 2005. Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother. 28:136–143.
   PubMed Web of Science ®Google Scholar
• Langemann T, Koller VJ, Muhammad A, Kudela P, Mayr UB, Lubitz W. 2010. The bacterial ghost platform system: production and applications. Bioeng Bugs. 1:326–336.
   PubMedGoogle Scholar
• Makino S, Watarai M, Tabuchi H, Shirahata T, Furuoka H, Kobayashi Y, Takeda Y. 2001. Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease. Microb Pathogenesis. 31:1–8.
   PubMed Web of Science ®Google Scholar
• Matise I, Cornick NA, Booher SL, Samuel JE, Bosworth BT, Moon HW. 2001. Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J Infect Dis. 183:347–350.
   PubMed Web of Science ®Google Scholar
• Matsui H, Suzuki M, Isshiki Y, Kodama C, Eguchi M, Kikuchi Y, Motokawa K, Takaya A, Tomoyasu T, Yamamoto T. 2003. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. Infect Immun. 71:30–39.
   PubMed Web of Science ®Google Scholar
• Mayr UB, Haller C, Haidinger W, Atrasheuskaya A, Bukin E, Lubitz W, Ignatyev G. 2005. Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun. 73:4810–4817.
   PubMed Web of Science ®Google Scholar
• McLamb BL, Gibson AJ, Overman EL, Stahl C, Moeser AJ. 2013. Early weaning stress in pigs impairs innate mucosal immune responses to enterotoxigenic E. coli challenge and exacerbates intestinal injury and clinical disease. PLoS One. 8:e59838.
   PubMed Web of Science ®Google Scholar
• Meisen I, Rosenbruck R, Galla HJ, Huwel S, Kouzel IU, Mormann M, Karch H, Muthing J. 2013. Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier. Glycobiology. 23:745–759.
   PubMed Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
   PubMed Web of Science ®Google Scholar
• Oanh TK, Nguyen VK, De Greve H, Goddeeris BM. 2012. Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid. Infect Immun. 80:469–473.
   PubMed Web of Science ®Google Scholar
• Overbergh L, Valckx D, Waer M, Mathieu C. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine. 11:305–312.
   PubMed Web of Science ®Google Scholar
• Ren W, Yu R, Liu G, Li N, Peng Y, Wu M, Yin Y, Li Y, Fatufe AA, Li T. 2013. DNA vaccine encoding the major virulence factors of Shiga toxin type 2e (Stx2e)-expressing Escherichia coli induces protection in mice. Vaccine. 31:367–372.
   PubMed Web of Science ®Google Scholar
• Riedmann EM, Kyd JM, Cripps AW, Lubitz W. 2007. Bacterial ghosts as adjuvant particles. Expert Rev Vaccines. 6:241–253.
   PubMed Web of Science ®Google Scholar
• Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science. 281:565–568.
   PubMed Web of Science ®Google Scholar
• Sarrazin E, Bertschinger H. 1997. Role of fimbriae F18 for actively acquired immunity against porcine enterotoxigenic Escherichia coli. Vet Microbiol. 54:133–144.
   PubMed Web of Science ®Google Scholar
• Sato T, Matsui T, Takita E, Kadoyama Y, Makino S, Kato K, Sawada K, Hamabata T. 2013. Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease. J Vet Med Sci. 75:1309–1315.
   PubMed Web of Science ®Google Scholar
• Shaban K, Amoudy HA, Mustafa AS. 2013. Cellular immune responses to recombinant Mycobacterium bovis BCG constructs expressing major antigens of region of difference 1 of Mycobacterium tuberculosis. Clin Vaccine Immunol. 20:1230–1237.
   PubMed Web of Science ®Google Scholar
• Smeds A, Pertovaara M, Timonen T, Pohjanvirta T, Pelkonen S, Palva A. 2003. Mapping the binding domain of the F18 fimbrial adhesin. Infect Immun. 71:2163–2172.
   PubMed Web of Science ®Google Scholar
• Sonntag AK, Bielaszewska M, Mellmann A, Dierksen N, Schierack P, Wieler LH, Schmidt MA, Karch H. 2005. Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl Environ Microb. 71:8855–8863.
   PubMed Web of Science ®Google Scholar
• Swain SL, Weinberg AD, English M, Huston G. 1990. IL-4 directs the development of Th2-like helper effectors. J Immun. 145:3796–3806.
   PubMed Web of Science ®Google Scholar
• Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W. 1996. Bacterial ghosts: non-living candidate vaccines. J Biotechnol. 44:161–170.
   PubMed Web of Science ®Google Scholar
• Tiels P, Verdonck F, Coddens A, Goddeeris B, Cox E. 2008. The excretion of F18 E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate. Vaccine. 26:2154–2163.
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:1–12.
   Web of Science ®Google Scholar
• Verdonck F, Tiels P, Van Gog K, Goddeeris B, Lycke N, Clements J, Cox E. 2007. Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18 Escherichia coli infection. Vet Immunol Immunop. 120:69–79.
   PubMed Web of Science ®Google Scholar
• Walcher P, Mayr UB, Azimpour-Tabrizi C, Eko FO, Jechlinger W, Mayrhofer P, Alefantis T, Mujer CV, DelVecchio VG, Lubitz W. 2004. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev Vaccines. 3:681–691.
   PubMedGoogle Scholar
• Wen J, Yang Y, Zhao G, Tong S, Yu H, Jin X, Du L, Jiang S, Kou Z, Zhou Y. 2012. Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway. Vaccine. 30:5733–5739.
   PubMed Web of Science ®Google Scholar
• Won G, Lee JH. 2016. Multifaceted immune responses and protective efficacy elicited by a recombinant autolyzed Salmonella expressing FliC flagellar antigen of F18+ Escherichia coli. Vaccine. 34:6335–6342.
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhang Y, Liu X. 2015. Efficient production of safety-enhanced Escherichia coli ghosts by tandem expression of PhiX 174 mutant gene E and staphylococcal nuclease A gene. Microbiol Res. 176:7–13.
   PubMed Web of Science ®Google Scholar